BC
CMD

Brinker Capital’s Cantel Medical Corporation CMD Stock Holding History

Brinker Capital’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,848
Closed -$354K – 1012
2018
Q3 		$354K Buy
3,848
+47
+1% +$4.48K 0.01% 815
2018
Q2 		$374K Buy
+3,801
New +$425K 0.01% 800

Other funds holding CMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Brinker Capital's CMD Position: Q4 2018 in Review

Brinker Capital sold out of Cantel Medical Corporation (CMD) in Q4 2018, closing a stake of 3,848 shares — an estimated $354K sold.

Brinker Capital first reported a position in CMD in Q2 2018 and held it in 2 quarters. The position peaked at $374K in Q2 2018. 253 funds tracked by Wall St. Rank hold CMD as of Q4 2018.

  • Brinker Capital reported no remaining Cantel Medical Corporation position as of Q4 2018 after selling out during the quarter.
  • Brinker Capital sold 3,848 Cantel Medical Corporation shares in Q4 2018, an estimated $354K.
  • Brinker Capital first reported a position in Cantel Medical Corporation in Q2 2018 and held it in 2 quarters.
  • Brinker Capital's Cantel Medical Corporation position peaked at $374K in Q2 2018.
  • 253 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2018.

Based on Brinker Capital's 13F filing for Q4 2018, filed 14 Feb 2019.